Catalyst Event
Sanofi (SNY) · Other
From KEDI U.S. Tech100 90% Participation + Daily Options Premium Index (KUSTC100P)
3/23/2026, 12:00:00 AM
On March 23, 2026, Sanofi announced an exclusive global licensing agreement with Kali Therapeutics for KT501, a tri-specific antibody for B cell-mediated autoimmune diseases, with Sanofi paying $180 million in upfront and near-term payments.
Korean Translation
2026년 3월 23일, 사노피는 B세포 매개 자가면역질환을 위한 3중 특이성 항체인 KT501에 대한 독점적 글로벌 라이선스 계약을 칼리 테라퓨틱스와 체결했다고 발표했으며, 선급금 및 단기 지급금으로 1억 8천만 달러를 지불함.
Related Recent Events
Micron Technology Inc. (MU) · Earnings Release
Micron's fiscal third-quarter 2026 earnings release is scheduled for June 24, 2026, scheduled. High importance is estimated as earnings releases for major semiconductor companies typically result in price impacts exceeding 10%.
6/24/2026, 12:00:00 AM
Apple Inc (AAPL) · Other
Apple's annual Worldwide Developers Conference (WWDC) is scheduled to begin on June 8, 2026, to unveil iOS 27 and major AI advancements; these updates are estimated to have a >5% price impact scheduled
6/8/2026, 12:00:00 AM
Palo Alto Networks Inc (PANW) · Earnings Release
Palo Alto Networks' next earnings release for Q3 2026 is scheduled for May 19, 2026. Low importance as it is a routine scheduled announcement with no results yet, scheduled.
5/19/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
Next earnings release for Q1 2026 is scheduled for 2026-05-14, with analysts forecasting an EPS of -$0.04. A neutral impact is expected as the market typically waits for actual results, so the release is forecasted and scheduled.
5/14/2026, 12:00:00 AM
AppLovin Corporation (APP) · Earnings Release
AppLovin's Q1 2026 earnings release is scheduled. Analysts forecast EPS of $3.41. Medium importance is estimated as earnings releases typically drive significant volatility scheduled.
5/13/2026, 12:00:00 AM
Advanced Micro Devices Inc (AMD) · Earnings Release
Q1 2026 earnings release scheduled for May 5, 2026. The company guided for Q1 revenue of approximately $9.8 billion, representing ~32% year-over-year growth but a sequential decline. Analysts forecast EPS of ~$1.27. Medium market impact as a major quarterly catalyst expected.
5/5/2026, 12:00:00 AM